Auriga Research

Name

Auriga Research

Legal name

Auriga Research Pvt. Ltd.

Website

https://aurigaresearch.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Contract Analytical Testing Services

NAICS

Testing Laboratories and Services (54138), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

akta.pro secondary industries

Bioanalytical Testing (PK/ADA/NAb) (HLAGADAA), Elemental Impurities & Trace Metals (ICP-MS) (HLAGADAJ), Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC), Clinical Research & Trial Central Laboratories (HLAFAMAL), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA)

Keywords

• Analytical testing services
• Pharmaceutical testing
• Food safety testing
• Contract research organization
• Clinical trial services

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Analytical Testing Services: Per-project analytical testing across pharmaceutical, food, water, cosmetics, herbal/AYUSH, medical device, and environmental matrices. Clients submit samples for specific test panels; reports are issued upon completion. Revenue is usage-based, driven by sample volume and test complexity. NABL-accredited reports issued for regulatory submissions.
2. Clinical Research (CRO) Services: Regulated clinical trial conduct (Phase II-IV), bioanalytical testing, pharmacovigilance, BA/BE monitoring, biostatistics, medical writing, real-world evidence studies, and clinical research for cosmetics/nutraceuticals/AYUSH claim substantiation. Project-based fees per study protocol. 370 investigator sites and 100+ SMO partners support trial delivery.
3. Certification & Audit Services: Third-party certification body services covering ISO 22000/FSMS, FSSAI Third Party Audit (Schedule 4), NABCB FS 025 certification, and FoSTaC food safety training. Revenue from certification audits, surveillance visits, and training programmes.
4. CDMO / Contract Manufacturing: Contract development and manufacturing services for personal care (private label, GMP manufacturing, formulation development, scale-up) and nutraceuticals (tablets, capsules, softgels, powders). Revenue from manufacturing batches and formulation development fees.
5. Inspection & Pre-shipment Services: Pre-shipment inspection services for agri-commodities (APEDA/EIC), pharmaceutical products, medical devices, and cosmetics. On-site environmental monitoring (air, water, effluent, noise, illumination). Revenue per inspection or monitoring visit.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Auriga Research operates an integrated contract testing, clinical research, and contract manufacturing network across five NABL-accredited ISO/IEC 17025:2017 laboratories in India. The company delivers regulated analytical testing for pharmaceutical, food, water, cosmetics, herbal/AYUSH, medical device, environmental, and clinical trial applications, complemented by a CRO division (Phase II-IV trials, pharmacovigilance, biostatistics, medical writing, BA/BE monitoring), a CDMO division (personal care and nutraceutical manufacturing), and an NABCB-accredited certification body.

Product overview

Auriga Research is an India-based multi-disciplinary contract testing, research, and manufacturing organization operating as a platform of five NABL-accredited ISO/IEC 17025:2017 laboratories (Delhi, Gurugram/Manesar, Bangalore, Baddi, Bahadurgarh) offering eight core testing verticals, a Contract Research Organization (CRO) division, a Contract Development and Manufacturing Organization (CDMO) division, and a Certification Division. The testing verticals span Pharmaceutical Testing, Food Testing, Water Testing, Cosmetics Testing, Herbal/AYUSH Testing, Medical Device Testing, Environmental Testing, and Clinical Trials. The CRO division provides Phase II–IV clinical trials, pharmacovigilance (including the AI-powered OnePharmacovigilance platform), site management, biostatistics and data management, real world evidence, medical writing, and BA/BE monitoring. Clinical research sub-services cover cosmetics and personal care studies, nutraceutical studies, and Ayurveda and herbal studies. The CDMO division offers personal care contract manufacturing and AYUSH-registered nutraceutical manufacturing. The Certification Division provides ISO 22000/FSMS, FSSAI third-party audit, and FoSTaC training. Internal infrastructure includes the YLIMS platform for sample and data management. The company serves over 12,000 clients across 30+ countries and is part of the Arbro Group (founded 1985), with Auriga Research established in 2007.

Differentiator

Problem solved

Functional benefit

Brands

• Alcatec Research Laboratories: Bahadurgarh facility operates under the name Alcatec Research Laboratories, specializing in environmental and industrial monitoring.

Products and services

• Pharmaceutical Testing NABL-accredited analytical testing for pharmaceutical drug substance, drug product, raw materials, in-process samples, and finished dosage forms, covering assay, stability (ICH Q1A), impurity profiling, dissolution, sterility (USP 71/IP), nitrosamine testing (ICH M7), bacterial endotoxin testing (LAL/rFC, USP 85/EP 2.6.14), method development and validation (ICH Q2(R2)), and excipient testing under IP, USP, BP, and EP monographs. For Indian and international pharmaceutical manufacturers requiring CDSCO, USFDA, ICH, and WHO prequalification-compliant data for ANDA, NDA, and CDSCO submissions.
• Food Testing NABL-accredited and FSSAI-approved food safety and quality testing covering pesticide residues (FSSAI, Codex, EU MRL, Japan Positive List), heavy metals (lead, arsenic, mercury, cadmium), nutritional labelling (macros, vitamins, energy), microbiological pathogens, shelf-life, adulteration (oil, spice, milk), and aflatoxin testing for dairy, spices, beverages, ghee, oils, cereals, honey, and packaged foods. For food manufacturers, processors, and food business operators (FBOs) requiring FSSAI licensing compliance and export certification.
• Water Testing NABL-accredited water quality analysis per IS 10500 and IS 14543 covering physical, chemical, heavy metal, and microbiological parameters. Includes FSSAI water reports for licensing, packaged drinking water, borewell water, pharmaceutical-grade water (WFI), wastewater/effluent per CPCB standards, turbidity, and alkalinity. For water utilities, purified drinking water companies, pharmaceutical manufacturers (WFI systems), and industrial facilities.
• Cosmetics Testing NABL-accredited and BIS-recognised safety and quality testing for cosmetics and personal care products covering physicochemical analysis, heavy metals (lead, arsenic, mercury, chromium), stability testing (real-time and accelerated per ICH), preservative efficacy (challenge testing per ISO 11930), microbiological testing, HRIPT patch testing, and BIS IS 4011 certification support. For cosmetics and personal care brands requiring BIS mandatory certification, market launch safety validation, and clinical claim substantiation.
• Herbal / AYUSH Testing AYUSH Ministry-accredited testing for Ayurvedic, Siddha, Unani, and herbal formulations covering heavy metals, pesticide residues (organochlorine, organophosphate), microbial limits, and standardisation/identity testing by HPTLC and DNA fingerprinting per API/IP monographs, plus AYUSH GMP audit services. For Ayurvedic, Siddha, Unani, and herbal product manufacturers requiring AYUSH Ministry regulatory compliance.
• Medical Device Testing NABL-accredited and CDSCO-recognised testing for Class A-D medical devices covering biocompatibility (ISO 10993 endpoints: cytotoxicity, sensitisation, irritation), bioburden (ISO 11737-1), sterility testing (ISO 11737-2), ETO residuals (ISO 10993-7), packaging validation (ISO 11607:2019), extractables and leachables (ISO 10993-18:2020), particulate matter (USP <788>/<790>), and material characterisation using FTIR, DSC, TGA, and ICP-MS. For medical device manufacturers requiring CDSCO MD-40, ISO 10993, FDA 510(k), and EU MDR submissions.
• Environmental Testing NABL-accredited CPCB/SPCB-aligned environmental monitoring covering air quality (PM2.5, ambient), stack emissions, wastewater/effluent, soil, solid and hazardous waste, noise mapping, illumination, indoor air quality, meteorological monitoring, and EIA baseline studies per SWM Rules 2016 and ZLD requirements. For manufacturing operations, infrastructure projects, and EPC contractors requiring environmental compliance reports for CPCB, MoEFCC, and state pollution control board regulations.
• Phase II-IV Clinical Trials CDSCO-approved Phase II to IV clinical trial conduct with a pan-India network of 370 investigator sites and 100+ SMO partners covering dose-finding, pivotal efficacy, post-marketing surveillance, bioanalytical testing per FDA/EMA/ICH M10 (LC-MS/MS), and PK/PD analysis using Phoenix WinNonLin. For pharma and biotech sponsors requiring DCGI/CDSCO clinical trial approvals and global regulatory submissions.
• Pharmacovigilance Services CDSCO-compliant pharmacovigilance services including PvMF/PSMF management, ICSR case processing with MedDRA coding, aggregate reporting (PSUR, PBRER, DSUR, PADER), signal detection and management (PRR/ROR/IC analytics under GVP Module IX), risk management plans, and E2B(R3) regulatory submission support. Powered by the proprietary OnePharmacovigilance cloud-based AI safety database. For pharmaceutical sponsors requiring CDSCO NDCT 2019 and EMA GVP compliance.
• Site Management Services Clinical site management services covering investigator site identification and feasibility, site initiation with IRB/EC submission, patient recruitment across a pan-India network of 370 sites, and on-site and remote source data verification (rSDV) across 5 regions. For pharmaceutical sponsors and CRO partners requiring multi-centre trial delivery.
• Biostatistics & Clinical Data Management Clinical data management and biostatistics services covering statistical analysis plan development (ICH E9), randomisation design, sample size calculation using nQuery and SAS, CDISC SDTM v3.3 and ADaM v2.1 data mapping, and end-to-end data management using Clinevo EDC with SAS and R. For clinical trial sponsors requiring regulatory-grade clinical data integrity.
• Real World Evidence Studies CDSCO-compliant real-world evidence studies including post-marketing obligations (PMO/NDCT 2019), active and passive PMS programmes, observational studies (prospective, retrospective, cross-sectional), patient registries, and HTA and payer evidence for outcomes research. For pharmaceutical and nutraceutical sponsors requiring post-marketing safety and efficacy evidence.
• Medical Writing Services Clinical and regulatory medical writing services covering CTD dossier modules 1-5 in CDSCO/EMA format, clinical study report (CSR) preparation per ICH E3, regulatory submissions (NDA, ANDA, product dossier), and systematic and narrative literature reviews. For pharmaceutical and biotech sponsors preparing global regulatory submissions.
• BA/BE Monitoring and PK Analysis Independent bioavailability/bioequivalence study monitoring and pharmacokinetic analysis using Phoenix WinNonLin, including protocol and SAP review support. Auriga provides monitoring and PK analysis for BE studies conducted by third parties. For pharmaceutical sponsors and CROs requiring independent BA/BE oversight for ANDA submissions.
• Cosmetics & Personal Care Clinical Studies NABL-accredited clinical research studies for cosmetics and personal care products covering HRIPT (Human Repeat Insult Patch Test), SPF in-vivo claim substantiation per ISO 24444, anti-ageing and moisturisation efficacy testing using Corneometer, Cutometer, and TEWL measurement, plus hair and scalp studies. For cosmetics brands requiring clinical evidence for marketing claims and BIS/ISO compliance.
• Nutraceutical Clinical Studies NABL-accredited clinical research for nutraceuticals covering bioavailability studies (absorption and PK profiling), dose-response efficacy trials, long-term safety and tolerance studies, and FSSAI health claim substantiation evidence. For nutraceutical, supplement, vitamin, and functional food brands requiring safety testing, efficacy evidence, and FSSAI regulatory compliance.
• Ayurveda & Herbal Clinical Studies NABL and AYUSH-accredited clinical research for classical Ayurvedic preparations, proprietary Ayurveda patent and proprietary medicine trials, heavy metal safety studies, long-term tolerability, and AYUSH documentation for traditional knowledge evidence dossiers. For Ayurvedic and herbal product manufacturers requiring AYUSH documentation and evidence dossiers.
• Certification Division Services NABCB-accredited third-party certification body services covering ISO 22000/FSMS food safety management system certification, FSSAI third-party audit (Schedule 4 compliance), FoSTaC food safety supervisor training, and NABCB FS 025 certification issuance. For food business operators and food manufacturers requiring accredited food safety certification.
• CDMO Personal Care Manufacturing Contract development and manufacturing services for personal care products covering formulation development (R&D, scale-up, technology transfer), private label manufacturing with ready formulations and custom branding, and GMP batch manufacturing at the Baddi facility. For personal care brands seeking end-to-end formulation, manufacturing, and regulatory support.
• Nutraceuticals CDMO Manufacturing AYUSH-registered GMP manufacturing for nutraceuticals including vitamins and minerals (tablets, capsules, effervescents), omega-3 and essential fatty acids (softgels, liquids), herbal and Ayurvedic supplements, protein and sports nutrition (powder blends, sachets), and collagen and probiotics. For nutraceutical, supplement, and sports nutrition brands requiring AYUSH-compliant GMP manufacturing.
• Inspection & Sampling Services Pre-shipment inspection and sampling services for agri-commodities (rice, sesame, groundnuts via APEDA), pharma and medical devices, cosmetics, and environmental monitoring, with APEDA and EIC approval and pan-India samplers at ISO 17025 labs. For exporters and importers requiring accredited pre-shipment inspection and conformity certificates.

Quantifiable outcome

• 12,000+ clients served across pharma, food, cosmetics, and more
• +6 more outcomes

Named customers9 records

Segments10 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• 100+ Site Management Organization (SMO) PartnerscoreOthersAuriga's Clinical Research Division operates with 100+ SMO partners across India for the delivery of Phase II-IV clinical trials. SMO partners provide investigator site management, patient recruitment, and on-site monitoring support across Auriga's network of 370 investigator sites in 5 regions. This partner ecosystem enables large-scale multi-centre trial conduct for pharmaceutical and biotech sponsors.
• International Courier and Logistics Partners (DHL, FedEx, UPS)minorOthersInternational sample import logistics coordinated through established DHL, FedEx, and UPS partnerships. Chain-of-custody documentation, import authorisation, NOC, end-use declaration, and customs brokerage handled by Auriga's logistics protocol. Typical customs clearance: 3–5 business days for standard analytical samples.
• 30+ Countries with Active Client RelationshipscoreOthersAuriga serves clients across 30+ countries including the US, UK, Germany, Netherlands, France, Italy, Spain, Japan, Australia, Singapore, Malaysia, Indonesia, UAE, Saudi Arabia, Qatar, Egypt, Nigeria, Kenya, South Africa, Brazil, Canada, Mexico, Bangladesh, and Sri Lanka. Reports are accepted by regulatory authorities and buyers in these markets through NABL ILAC mutual recognition, enabling Indian manufacturers to export with Auriga-issued accredited certificates.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Vimta Labs: Indian NABL-accredited CRO and analytical testing laboratory offering pharma, food, and clinical research services. Closest Indian listed peer to Auriga with overlapping verticals (pharma testing, clinical research, bioanalytical) and similar customer base of Indian pharma manufacturers.
• Syngene International: Indian integrated CRO/CDMO offering discovery, development, and manufacturing services to global pharma. Comparable in CRO scale and global pharma client base; Auriga is more testing-led while Syngene is more discovery/manufacturing-led, but both serve regulated pharma end markets.
• Aragen Life Sciences (formerly GVK Biosciences): Indian contract research and CDMO serving global pharma and biotech. Comparable in CRO scale, India-based operations, and integrated discovery-to-development service model; competes with Auriga's CRO division for bioanalytical, BA/BE, and clinical pharmacology work.
• Sai Life Sciences: Indian CRO/CDMO offering drug discovery, development, and manufacturing services to global pharma. Comparable integrated CRO scale and target customer base (global pharma sponsors); competes with Auriga's CRO division for biologics, small molecule, and bioanalytical work.
• Veeda Clinical Research: Indian CRO specialising in BA/BE, bioanalytical, and clinical research. Directly comparable to Auriga's bioanalytical and clinical research services for generic and innovative pharma sponsors.
• Lambda Therapeutic Research: Indian CRO offering clinical research, BA/BE, bioanalytical, and clinical data management. Directly comparable to Auriga's CRO division in scope and target pharma/biotech sponsors.

Broad incumbents

• Eurofins Scientific: Global leader in bioanalytical, pharmaceutical, food, and environmental testing with hundreds of labs worldwide. Comparable service breadth (pharma, food, environment) but at vastly larger scale with owned local labs in client geographies — a structural advantage Auriga lacks.
• SGS: Global testing, inspection, and certification company with pharma, food, and environmental testing capabilities. Comparable TIC service portfolio but operates across far more geographies with local lab presence.
• Intertek: Global TIC services provider with pharma, food, and cosmetics testing capabilities. Comparable regulated-industry testing focus but operates a global local-lab network that Auriga does not match.
• TÜV SÜD: Global testing, inspection, certification, and training company with pharma, food, and medical device testing. Comparable certification body and regulated-industry testing services; significant Indian presence that overlaps with Auriga's certification and testing verticals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/aurigaresearch
• Facebookfacebook.com/aurigaresearch
• LinkedInlinkedin.com/company/auriga-research-ltd.

Compliance25 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Auriga Research